Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SLSN
SLSN logo

SLSN Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.970
Open
0.970
VWAP
0.91
Vol
60.57K
Mkt Cap
66.98M
Low
0.800
Amount
54.89K
EV/EBITDA(TTM)
38.18
Total Shares
70.61M
EV
78.88M
EV/OCF(TTM)
--
P/S(TTM)
0.98
Solesence, Inc., formerly Nanophase Technologies Corporation, provides healthcare solutions across beauty and life science categories. It is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The Company partners with global and indie brands, leveraging its proprietary Active Stress Defense technology suite (Original Active Stress Defense, Kleair, and Bloom) to bring environmental protection beauty products to market via over a dozen market-ready offerings that embrace self-expression, health care, and self-care across skin care and color cosmetic categories. It also offers custom development, with turnkey options available across all paths to market. The Company’s products are formulated using its own mineral sunscreen actives, which are produced in its Chicagoland facility where it has been producing sunscreen actives, including the zinc oxide sunscreen active.
Show More

Events Timeline

(ET)
2026-02-26
08:20:00
Solesence Appoints Yoolie Park as VP of Brand Partnerships
select
2025-11-11 (ET)
2025-11-11
07:01:26
Solesence announces Q3 earnings per share of 2 cents, down from 4 cents a year ago.
select
2025-11-10 (ET)
2025-11-10
08:26:47
Solesence names Yoana Dvorzsak as Vice President of Innovation and Product Integrity
select
2025-09-03 (ET)
2025-09-03
08:09:27
Solesence names Kevin Cureton as its new president and CEO.
select
2025-06-24 (ET)
2025-06-24
08:04:29
Solesence to join Russell 3000, Russell 2000 Indexes
select
2025-06-02 (ET)
2025-06-02
08:04:30
Solesence expands debt facilities
select

News

seekingalpha
9.5
03-31seekingalpha
PinnedSolesence Q4 Financial Highlights
  • Slight Revenue Decline: Solesence reported Q4 revenue of $12.5 million, a 0.6% year-over-year decrease, indicating slight fluctuations in market demand that may impact future sales strategies and market positioning.
  • Significant Gross Profit Increase: The gross profit for Q4 reached $3.4 million, up 21.4% from $2.8 million in the same period of 2024, demonstrating positive progress in cost control and product pricing, thereby enhancing profitability.
  • Improved Gross Margin: The gross margin in Q4 was 27%, a 5 percentage point increase from 22% in 2024, reflecting the company's success in operational efficiency and product mix optimization, which may attract more investor interest.
  • Net Income Turnaround: Q4 net income was approximately $0.2 million, compared to a net loss of $0.6 million in the same period of 2024, indicating a significant improvement in profitability that could bolster market confidence and support future growth plans.
seekingalpha
9.5
03-31seekingalpha
Solesence, Inc. Q4 2025 Earnings Call Insights
  • Financial Performance Overview: Solesence reported Q4 2025 revenue of $12.5 million and gross profit of $3.4 million, with a gross margin of 27%, reflecting financial pressure due to transition costs and operational inefficiencies from facility consolidation, resulting in a net income of $163,000.
  • Strategic Plan Announcement: CEO Kevin Cureton emphasized that 2026 will be an execution-focused year with the launch of the 'Transform and Transcend' initiative, aimed at enhancing product design, labor efficiency, and inventory control to achieve profitable growth, which is expected to bolster the company's competitive position in the market.
  • Leadership Changes: The company appointed Laura Riffner as CFO in September 2025 and added Yoolie Park as Vice President of Brand Partnerships, reflecting a strategic focus on leveraging new leadership to drive profitable growth and effective execution of the company's plans.
  • Future Outlook: CFO Riffner set a 30% gross margin target for 2026 and anticipates improving free cash flow through working capital actions, despite facing near-term pressures from changes in customer order patterns and weak sell-through from a large mass-market customer.
SeekingAlpha
9.5
2025-07-31SeekingAlpha
Nanophase Technologies GAAP EPS of $0.04, revenue of $20.4M
  • Financial Performance: Nanophase Technologies reported a Q2 GAAP EPS of $0.04 and revenue of $20.4 million.

  • Market Developments: Solesence, Inc. is experiencing growth but faces stock price challenges, while other materials stocks are joining the Russell Microcap Index.

Newsfilter
8.5
2025-06-02Newsfilter
Solésence Expands Debt Facilities to Fuel Growth Initiatives
  • Loan Agreement Amendments: Solésence, Inc. has amended its loan agreements to increase borrowing capacity from $14.2 million to $23.0 million and extended the maturity date to April 30, 2027, providing financial flexibility for strategic objectives.

  • Company Overview: Solésence is a leader in health care solutions within beauty and life sciences, focusing on innovative mineral-based sun protection and empowering brand partners through enhanced product offerings.

Valuation Metrics

The current forward P/E ratio for Solesence Inc (SLSN.O) is 11.36, compared to its 5-year average forward P/E of 3.64. For a more detailed relative valuation and DCF analysis to assess Solesence Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
3.64
Current PE
11.36
Overvalued PE
10.26
Undervalued PE
-2.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding SLSN

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Solesence Inc (SLSN) stock price today?

The current price of SLSN is 0.9486 USD — it has increased 5.33

What is Solesence Inc (SLSN)'s business?

Solesence, Inc., formerly Nanophase Technologies Corporation, provides healthcare solutions across beauty and life science categories. It is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The Company partners with global and indie brands, leveraging its proprietary Active Stress Defense technology suite (Original Active Stress Defense, Kleair, and Bloom) to bring environmental protection beauty products to market via over a dozen market-ready offerings that embrace self-expression, health care, and self-care across skin care and color cosmetic categories. It also offers custom development, with turnkey options available across all paths to market. The Company’s products are formulated using its own mineral sunscreen actives, which are produced in its Chicagoland facility where it has been producing sunscreen actives, including the zinc oxide sunscreen active.

What is the price predicton of SLSN Stock?

Wall Street analysts forecast SLSN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLSN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Solesence Inc (SLSN)'s revenue for the last quarter?

Solesence Inc revenue for the last quarter amounts to 12.48M USD, decreased -0.67

What is Solesence Inc (SLSN)'s earnings per share (EPS) for the last quarter?

Solesence Inc. EPS for the last quarter amounts to 0.00 USD, decreased -100.00

How many employees does Solesence Inc (SLSN). have?

Solesence Inc (SLSN) has 98 emplpoyees as of April 01 2026.

What is Solesence Inc (SLSN) market cap?

Today SLSN has the market capitalization of 66.98M USD.